Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 10 - 22 save search
Global Radiation Oncology Markets, 2021-2028 - Increasing Application Of Radiopharmaceuticals, Rising Prevalence Of Cancer, & Rising Adoption Of Radiotherapy
Published: 2021-10-22 (Crawled : 19:00) - prnewswire.com
ARAY | $2.175 1.64% 1.61% 1.2M
|
Health Technology
| Email alert
Add to watchlist
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
| Email alert
Add to watchlist
application therapy cancer iot
Achilles Therapeutics Presents Data at the 2021 European Society for Gene and Cell Therapy (ESGCT) Congress
Published: 2021-10-22 (Crawled : 13:00) - biospace.com/
ACHL | $0.7827 -0.03% -0.03% 430K
|
Manufacturing
| Email alert
Add to watchlist
therapy europe esg
Blue Wolf Capital to Acquire CIVCO Radiotherapy from Roper Technologies
Published: 2021-10-22 (Crawled : 12:00) - biospace.com/
ROP | $539.11 0.89% 0.88% 580K
|
Electronic Technology
|
| O: 1.82%
H: 3.06%
C: -0.57%
therapy iot
Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress
Published: 2021-10-22 (Crawled : 12:00) - globenewswire.com
GBIO | News | $2.805 0.18% 0.18% 150K
|
Health Technology
|
| O: 0.99%
H: 1.53%
C: 1.02%
europe therapy retina liver
Achilles Therapeutics Presents Data at the 2021 European Society for Gene and Cell Therapy (ESGCT) Congress Demonstrating its Proprietary Manufacturing Process Can Generate Potent, Personalized Anti-Cancer Cell Therapy Candidates in Multiple Solid Tumor Types
Published: 2021-10-22 (Crawled : 12:00) - globenewswire.com
ACHL | $0.7827 -0.03% -0.03% 430K
|
Manufacturing
| Email alert
Add to watchlist
europe therapy cancer esg solid tumors
Baptist Health South Florida to Acquire a Second ViewRay MRIdian® MR-Guided Radiation Therapy System
Published: 2021-10-22 (Crawled : 11:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
therapy radiation therapy
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer (TNBC)
Published: 2021-10-22 (Crawled : 11:00) - biospace.com/
MRK | $126.94 0.92% 0.0% 7.8M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
treatment europe therapy cancer breast cancer keytruda
Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers
Published: 2021-10-22 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: -0.41%
TAK | News | $13.36 0.91% -0.52% 1.6M
|
Health Technology
|
| O: 0.07%
H: 0.5%
C: 0.29%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
therapy
Roper Technologies to Divest CIVCO Radiotherapy
Published: 2021-10-22 (Crawled : 11:00) - globenewswire.com
ROP | $539.11 0.89% 0.88% 580K
|
Electronic Technology
|
| O: 1.82%
H: 3.06%
C: -0.57%
therapy iot technology
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.